NYSE:MOHHealthcare
Molina Reworks Product Mix With MAPD Exit And Medicaid Focus
Molina Healthcare (NYSE:MOH) plans to exit the Medicare Advantage Prescription Drug business starting in 2027.
The company is reducing its Marketplace exposure as part of a broader reshaping of its product portfolio.
Molina is ramping up its Florida CMS Kids contract, which has different profitability dynamics compared with Medicare and Marketplace plans.
Molina Healthcare operates as a managed care company with a focus on government sponsored health programs, and these moves shift emphasis...